IL1B and congenital rubella syndrome: Studies have revealed that CRS activates glial cells to release proinflammatory factors, such as interleukin-1β (IL-1β) and tumor necrosis factor α (TNF- α) (Deak et al., 2015), which in turn promotes apoptosis, ultimately leading to apoptosis.